Silverfin false 30/04/2023 14/04/2022 30/04/2023 D J Barron 14/04/2022 M B Nakan 14/04/2022 M A H Rausing 27/10/2022 29 November 2023 no description of principal activity 14047305 2023-04-30 14047305 bus:Director1 2023-04-30 14047305 bus:Director2 2023-04-30 14047305 bus:Director3 2023-04-30 14047305 core:CurrentFinancialInstruments 2023-04-30 14047305 core:ShareCapital 2023-04-30 14047305 core:SharePremium 2023-04-30 14047305 core:RetainedEarningsAccumulatedLosses 2023-04-30 14047305 core:OtherResidualIntangibleAssets 2022-04-13 14047305 2022-04-13 14047305 core:OtherResidualIntangibleAssets 2023-04-30 14047305 core:OtherPropertyPlantEquipment 2022-04-13 14047305 core:OtherPropertyPlantEquipment 2023-04-30 14047305 core:CostValuation 2022-04-13 14047305 core:AdditionsToInvestments 2023-04-30 14047305 core:CostValuation 2023-04-30 14047305 core:ProvisionsForImpairmentInvestments 2022-04-13 14047305 core:ProvisionsForImpairmentInvestments 2023-04-30 14047305 core:CurrentFinancialInstruments 1 2023-04-30 14047305 bus:OrdinaryShareClass1 2023-04-30 14047305 2022-04-14 2023-04-30 14047305 bus:FullAccounts 2022-04-14 2023-04-30 14047305 bus:SmallEntities 2022-04-14 2023-04-30 14047305 bus:AuditExemptWithAccountantsReport 2022-04-14 2023-04-30 14047305 bus:PrivateLimitedCompanyLtd 2022-04-14 2023-04-30 14047305 bus:Director1 2022-04-14 2023-04-30 14047305 bus:Director2 2022-04-14 2023-04-30 14047305 bus:Director3 2022-04-14 2023-04-30 14047305 core:OtherResidualIntangibleAssets core:TopRangeValue 2022-04-14 2023-04-30 14047305 core:OtherPropertyPlantEquipment core:TopRangeValue 2022-04-14 2023-04-30 14047305 core:OtherResidualIntangibleAssets 2022-04-14 2023-04-30 14047305 core:OtherPropertyPlantEquipment 2022-04-14 2023-04-30 14047305 bus:OrdinaryShareClass1 2022-04-14 2023-04-30 iso4217:GBP xbrli:pure xbrli:shares

Company No: 14047305 (England and Wales)

ENVISION ENT LTD

Unaudited Financial Statements
For the financial period from 14 April 2022 to 30 April 2023
Pages for filing with the registrar

ENVISION ENT LTD

Unaudited Financial Statements

For the financial period from 14 April 2022 to 30 April 2023

Contents

ENVISION ENT LTD

STATEMENT OF FINANCIAL POSITION

As at 30 April 2023
ENVISION ENT LTD

STATEMENT OF FINANCIAL POSITION (continued)

As at 30 April 2023
Note 30.04.2023
£
Fixed assets
Intangible assets 3 90,455
Tangible assets 4 548
Investments 5 40,000
131,003
Current assets
Debtors 6 10,208
Cash at bank and in hand 7 436,217
446,425
Creditors: amounts falling due within one year 8 ( 16,649)
Net current assets 429,776
Total assets less current liabilities 560,779
Net assets 560,779
Capital and reserves
Called-up share capital 9 116
Share premium account 758,896
Profit and loss account ( 198,233 )
Total shareholders' funds 560,779

For the financial period ending 30 April 2023 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The financial statements of Envision Ent Ltd (registered number: 14047305) were approved and authorised for issue by the Director. They were signed on its behalf by:

M B Nakan
Director

29 November 2023

ENVISION ENT LTD

NOTES TO THE FINANCIAL STATEMENTS

For the financial period from 14 April 2022 to 30 April 2023
ENVISION ENT LTD

NOTES TO THE FINANCIAL STATEMENTS

For the financial period from 14 April 2022 to 30 April 2023
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial period, unless otherwise stated.

General information and basis of accounting

Envision Ent Ltd (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is 35 Ballards Lane, London, N3 1XW, England, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Intangible assets

Intangible assets are stated at cost or valuation, net of amortisation and any provision for impairment. Amortisation is provided on all intangible assets at rates to write off the cost or valuation of each asset over its expected useful life as follows:

Other intangible assets 5 years straight line
Tangible fixed assets

Tangible fixed assets are stated at cost or valuation, net of depreciation and any provision for impairment. Depreciation is provided on all tangible fixed assets, other than investment property and freehold land, at rates calculated to write off the cost or valuation, less estimated residual value, of each asset on a straight-line or reducing balance basis over its expected useful life, as follows:

Plant and machinery etc. 3 years straight line

Residual value represents the estimated amount which would currently be obtained from disposal of an asset, after deducting estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life.

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

Impairment of assets

Assets, other than those measured at fair value, are assessed for indicators of impairment at each Statement of Financial Position date. If there is objective evidence of impairment, an impairment loss is recognised in the Statement of Income and Retained Earnings as described below.

Trade and other debtors

Trade and other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method less impairment losses for bad and doubtful debts, except where the effect of discounting would be immaterial. In such cases the receivables are stated at cost less impairment losses for bad and doubtful debts.

Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in creditors: amounts falling due within one year.

Trade and other creditors

Trade and other creditors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest rate method, unless the effect of discounting would be immaterial, in which case they are stated at cost.

Financial instruments

The Company only enters into basic financial instruments and transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to and from related parties and investments in non-puttable ordinary shares.

2. Employees

Period from
14.04.2022 to
30.04.2023
Number
Monthly average number of persons employed by the Company during the period, including directors 3

3. Intangible assets

Other intangible assets Total
£ £
Cost
At 14 April 2022 0 0
Additions 90,455 90,455
At 30 April 2023 90,455 90,455
Accumulated amortisation
At 14 April 2022 0 0
At 30 April 2023 0 0
Net book value
At 30 April 2023 90,455 90,455

4. Tangible assets

Plant and machinery etc. Total
£ £
Cost
At 14 April 2022 0 0
Additions 742 742
At 30 April 2023 742 742
Accumulated depreciation
At 14 April 2022 0 0
Charge for the financial period 194 194
At 30 April 2023 194 194
Net book value
At 30 April 2023 548 548

5. Fixed asset investments

Other investments Total
£ £
Carrying value before impairment
At 14 April 2022 0 0
Additions 40,000 40,000
At 30 April 2023 40,000 40,000
Provisions for impairment
At 14 April 2022 0 0
At 30 April 2023 0 0
Carrying value at 30 April 2023 40,000 40,000

6. Debtors

30.04.2023
£
Other debtors 10,208

7. Cash and cash equivalents

30.04.2023
£
Cash at bank and in hand 436,217

8. Creditors: amounts falling due within one year

30.04.2023
£
Trade creditors 15,868
Amounts owed to connected companies 304
Other creditors 477
16,649

9. Called-up share capital

30.04.2023
£
Allotted, called-up and fully-paid
11,568 Ordinary shares of £ 0.01 each 116

10. Related party transactions

Transactions with the entity's directors

30.04.2023
£
Other creditors 274

Included within other creditors is the above balance owed to the directors. The balance is secured and interest free with no fixed repayment terms.